A study to evaluate the efficacy and safety of rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease as measured by intravascular ultrasonography.
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2016
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms COSMOS
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 30 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Dec 2007 Status changed from recruiting to in progress.